Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: The Microalbuminuria Education and Medication Optimisation (MEMO) study

Diabetes Research and Clinical Practice

Volumn 93, Issue 3, 2011, Pages 328-336

  Crasto, W ^a,c   Jarvis, J ^a   Khunti, K ^c   Skinner, T C ^b   Gray, L J ^c   Brela, J ^a   Troughton, J ^a   Daly, H ^a   Lawrence, I G ^a   McNally, P G ^a   Carey, M E ^a   Davies, M J ^a,c  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Microalbuminuria; Structured education; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; THIAZOLIDINE DERIVATIVE;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL STUDY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; EDUCATION; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH EDUCATION; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; ASPIRIN; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; RISK FACTORS;

EID: 80052732201     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.05.008     Document Type: Article

References (29)

1. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348(5):383-393.
2. Gaede P., Lund-Anderson H., Parving H.H., Pederson O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358(6):580-591.
3. Joss N., Paterson K.R., Deighan C.J., Simpson K., Boulton-Jones J.M. Diabetic nephropathy: how effective is treatment in clinical practice?. QJM 2002, 95(1):41-49.
4. Gaede P., Beck M., Vedel P., Pederson O. Limited impact of lifestyle education in patients with type 2 diabetes mellitus and microalbuminuria: results from a randomised intervention study. Diab Med 2000, 18(2):104-108.
5. Department of Health and Diabetes UK. Structured patient education in diabetes: report from the Patient Education Working Group; 2005.
6. Davies M.J., Heller S., Skinner T.C., Campbell M.J., Carey M.E., Cradock S., et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ 2008, 336:491-495.
7. Trento M., Passera P., Tomalino M., Bajardi M., Pomero F., Allione A., et al. Group visits improve metabolic control in type 2 diabetes. Diabetes Care 2001, 24:995-1000.
8. Khunti K., Skinner T.C., Heller S., Carey M.E., Dallosso H.M., Davies M.J., et al. Biomedical, lifestyle and psychosocial characteristics of people newly diagnosed with type 2 diabetes: baseline data from the DESMOND randomized controlled trial. Diab Med 2008, 25(12):1454-1461.
9. Kidney Disease Quality Outcomes Initiative Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. AJKD 2002, 39:S1-S266.
10. Leicestershire diabetes guidelines; 2002. http://www.leicestershirediabetes.org.uk/display/templatedisplay2.asp?sectionid=458.
11. National Collaborating Centre for Chronic Conditions. Type 2 Diabetes: national clinical guideline for management in primary and secondary care (update). Royal College of Physicians of London; 2008.
12. National Institute for Clinical Excellence. Chronic kidney disease: NICE guidelines: CG73; 2008.
13. Bandura A. Self-efficacy: toward a unifying theory of behavioural change. Psychol Rev 1997, 84:191-215.
14. Skinner T.C., Carey M.E., Cradock S., Daly H., Davies M.J., on behalf of the DESMOND Collaborative Diabetes education and self-management for ongoing and newly diagnosed (DESMOND): process modelling of pilot study. Patient Educ Couns 2006, 64(1):369-377.
15. Friedewald W.T., Levy R.J., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
16. Holman R.R., Thorne K.I., Farmer A.J., Davies M.J., et al. For the 4-T study group: addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 2007, 357:1716-1730.
17. Stevens R.J., Kothari V., Adler A.I., Stratton I.M. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci 2001, 101:671-679.
18. Rachmani R., Levi Z., Slavachevski I., Avin M., Ravid M. Teaching participants to monitor their risk factors retards the progression of vascular complications in high-risk participants with T2DM mellitus - a randomised prospective study. Diab Med 2002, 19:385-392.
19. Altman D.G., Schulz K.F., Moher D., Egger M., Davidoff F., Elbourne D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Int Med 2001, 134:663-694.
20. Dinneen S.F., Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Int Med 1997, 157:1413-1418.
21. Neil A., Hawkins M., Potok M., Thorogood M., Cohen D., Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes 1993, 16:996-1003.
22. Gerstein H.C., Miller M.E. Action to control cardiovascular risk in diabetes study group: effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559.
23. Miller M.E., Bonds D.E., Gerstein H.C., Seaquist E.R., Bergenstal R., et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2009, 339:b5444.
24. Loveman E., Frampton G.K., Clegg A.J. The clinical effectiveness of diabetes education models for type 2 diabetes: a systematic review. Health Technol Assess 2008, 12(9):1-136.
25. National Institute for Health and Clinical Excellence. Technology appraisal 60. Guidance on the use of patient-education models for diabetes; 2003.
26. Department of Health: National Service Framework for Diabetes. Department of Health; 2002.
27. International Diabetes Federation. Position statement - diabetes education: a right for all; 2004.
28. American Diabetes Association Standards of medical care in diabetes. Diabetes Care 2003, 28(Suppl. 1):S4-S36.
29. Vaghela P., Ashworth M., Schofield P., Gulliford M.C. Population intermediate outcomes of diabetes under pay-for-performance incentives in England from 2004 to 2008. Diabetes Care 2009, 32:427-429.